Zhenkui Pan - Concepedia

Author

Zhenkui Pan

First Affiliated Hospital of Guangzhou Medical University ORCID

Also Known As

Hengrui Liang, Zhen-Kui Pan, Zhenkui PAN, Zhenkui Pan

Publications

616

Citations

H-Index

Concepts

All Affiliations

First Affiliated Hospital of Guangzhou Medical University Qingdao University Guangzhou Medical University Qingdao Municipal Hospital State Key Laboratory of Respiratory Disease

About

Zhenkui Pan is an author at First Affiliated Hospital of Guangzhou Medical University specializing in oncology, medicine, and drug therapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	62
2	Immunology	1	1	23
3	Pathology	1	1	23
4	Pharmacology	1	1	39
5	Cancer Genetics	1	1	23

Zhenkui Pan

Publications

362

Citations

H-Index

Page 1

	Year	Citations
Clinicopathological and prognostic significance of programmed cell death ligand1 (PD-L1) expression in patients with non-small cell lung cancer: a meta-analysis. Zhenkui Pan, Feng Ye, Xuan Wu, PubMed	2015	139
Profiling Tumor Immune Microenvironment of Non-Small Cell Lung Cancer Using Multiplex Immunofluorescence Haoxin Peng, Xiangrong Wu, Ran Zhong, Frontiers in Immunology	2021	62
PD‐(L)1 inhibitors <i>vs</i>. chemotherapy <i>vs</i>. their combination in front‐line treatment for NSCLC: An indirect comparison Hengrui Liang, Zhichao Liu, Xiuyu Cai, International Journal of Cancer OncologyFront‐line TreatmentPd-l1 ExpressionMedicineImmune Checkpoint Inhibitor	2019	39
The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures Qihua He, Peiling Xin, Mingzhe Zhang, Translational Lung Cancer Research	2019	36
The incidence of lymph node metastasis in patients with different oncogenic driver mutations among T1 non-small-cell lung cancer Zhichao Liu, Hengrui Liang, Jie Lin, Lung Cancer Somatic VariantMedicineImmunologyPathologyLymph Node Metastasis	2019	23
PD-L1 expression with respect to driver mutations in non-small cell lung cancer in an Asian population: a large study of 1370 cases in China Caichen Li, Jun Liu, Zhanhong Xie, Therapeutic Advances in Medical Oncology	2020	23
Association between certain non–small cell lung cancer driver mutations and predictive markers for chemotherapy or programmed death‐ligand 1 inhibition Wenhua Liang, Minzhang Guo, Zhenkui Pan, Cancer Science	2019	15
Profiling tumor immune microenvironment of non-small cell lung cancer using multiplex immunofluorescence Haoxin Peng, Xiangrong Wu, Ran Zhong,	2021	13
Development and validation of a deep transfer learning-based multivariable survival model to predict overall survival in lung cancer Feng Zhu, Ran Zhong, Feng Li, Translational Lung Cancer Research	2023	12

Page 1